1991
DOI: 10.1016/0925-4927(91)90025-l
|View full text |Cite
|
Sign up to set email alerts
|

Stability of resting deoxyglucose metabolic values in PET studies of schizophrenia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
6
0

Year Published

1992
1992
2013
2013

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 35 publications
(6 citation statements)
references
References 16 publications
0
6
0
Order By: Relevance
“…Twenty‐nine studies (9, 12, 13, 16, 17, 31–54) provided global or hemisphere data (in which case left and right values were averaged). The pooled effect size for these was −0.27 (CI −0.39 to −0.15) with the negative sign indicating reduced flow/metabolism in schizophrenia (see Table 1).…”
Section: Whole Brain Blood Flow/metabolismmentioning
confidence: 99%
See 2 more Smart Citations
“…Twenty‐nine studies (9, 12, 13, 16, 17, 31–54) provided global or hemisphere data (in which case left and right values were averaged). The pooled effect size for these was −0.27 (CI −0.39 to −0.15) with the negative sign indicating reduced flow/metabolism in schizophrenia (see Table 1).…”
Section: Whole Brain Blood Flow/metabolismmentioning
confidence: 99%
“…The original 29 studies were not homogeneous ( Q =75.79, P < 0.0001), but homogeneity was achieved by exclusion of seven outliers (9, 31, 34, 40, 42, 45, 47) This reduced the effect size to −0.26 (CI −0.40 to −0.11; Q = 29.60, P = 0.10). Four of the seven outliers had large negative values, but otherwise they showed no common features.…”
Section: Whole Brain Blood Flow/metabolismmentioning
confidence: 99%
See 1 more Smart Citation
“…35,36 Positron emission tomography (PET) scan measurement of glucose metabolism was selected based on its high reliability and availability combined with its established use for studies of baseline scan patterns in depression and effects of various antidepressant treatments. 22,23,28,34,3743 Our aim was to define an imaging TSB for these 2 potential first-line treatments, ie, a brain activity pattern that distinguishes escitalopram remitters from both escitalopram nonresponders and CBT remitters while concurrently distinguishing CBT remitters from both CBT nonresponders and escitalopram remitters.…”
mentioning
confidence: 99%
“…Repeated studies with magnetic resonance imaging (MRI) have indicated an average repositioning error of about 2 mm (Buchsbaum et al 1992a). Test-retest correlations for FDG PET show that it is a highly reliable method (Bartlett et al 1991). For the PET procedure, subjects slept alone in a dark, quiet individual bedroom and were studied according to previously described methods (Buchsbaum et al 1989).…”
Section: Pet Scanningmentioning
confidence: 99%